Lymphoproliferative Disorders

Bleesing JJH, Brown MR, et al. A composite picture of TcRa/ß+, CD4-, CD8- T cells (a/ß-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin Immun 2002;104:21-30.

Bleesing JJH, Straus SE, et al. Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival. Pediatr Clin North Am 2000;47: 1291-1310.

Chiocchetti A, Indelicato M, et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lym-phoproliferation. Blood 2004;103:1376-82.

Cohen JI. Benign and malignant Epstein-Barr virus-associated B-cell lymphoprolif-erative diseases. Semin Hematol 2003;40:116-23.

Ganne V, Siddiqi N, et al. Humanized anti-CD20 monoclonal antibody (rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant 2003;17:417-22.

Garrett TJ, Chadburn A. Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. Cancer 1993;72:2782-85.

Hsueh C, Gonzalez-Crussi F, Murphy SB. Testicular angiocentric lymphoma of post thymic T-cell type in a child with T-cell acute lymphoblastic leukemia in remission. Cancer 1993;72:1801-5.

Medcinos LJ, Harris NL. Immunohistologic analysis of small lymphocytic infiltrates of the orbit and conjunctiva. Hum Pathol 1990;21:1126-31.

Paulli M, Berti E, Rosso R, Boveri E, et al. CD30/Ki-1 positive lymphoproliferative disorders of the skin—clinicopathological correlation and statistical analysis of 86 cases: a multicentric study of the European Organization of Research and treatment of cancer cutaneous lymphoma project groups. J Clin Oncol 1995;13:1343-54.

Peiper SC. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein-Barr virus in pathogenesis. Blood 1993;82:687-90.

Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993;636-47.

Seemayer TA, Gross TG, et al. X-linked lymphoproliferative diseases: twenty-five years after the discovery. Pediatr Res 1995;38:471-78.

Steinberg AD, Seldin MF, Jaffe ES, Smith MR, et al. Angioimmunoblastic lym-phadenopathy with dysproteinemia. Ann Intern Med 1998;108:575-84.

Straathof KCM, Bollard CM, et al. Immunotherapy for Epstein-Barr virus-associated cancers in children. Oncologist 2003;8:83-98.

Sumegi J, Huang D, et al. Correction of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lym-phoproliferative disease. Blood 2000;96:3118-25.

Tsatalas C, Margaritis D, et al. Successful treatment of angioimmunoblastic lym-phadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. Acta Haematol 2001;105:106-8.

Uphouse WJ, Woods JC. Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer 1987;60:2161-4.

Van Der Werff Ten Bosch J, Schotte P, et al. Reversion of autoimmune lymphoprolif-erative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations. Br J Haematol 2002;117:176-88.

Zirbel GM, Gellis SE, Kadin ME, Esterly NB. Lymphomatoid papulosis in children. J Am Acad Dermatol 1995;33:741-8.


Arico M, Biondi A, et al. Juvenile myelomonocytic leukemia. Blood 1997;90:479-88.

Barnard DR, Lange B, et al. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood 2002;100:427-34.

Flotho C, Valcmonica S, et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999;13:32-7.

Hasle H, Fenu S, et al. International prognostic scoring system for childhood MDS and JMML. Leukemia 2000;14:968.

Hasle H, Niemeyer C. Myelodysplastic syndrome and juvenile myelomonocytic leukemia in children. In: Bennett JM, editor. The Myelodysplastic Syndromes: Pathophysiology and Clinical Management. New York: Marcel Dekker, 2002;299-344.

Kang JH, Shin HY, et al. Novel regimen for treatment of juvenile myelomonocytic leukemia (JMML). Leukemia Res 2004;28:167-70.

Lange BJ, Kobrinsky N, et al. Distinctive demography, biology, and outcome of acute myeloid leukemia, and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 1998;91:608-15.

Luna-Fineman S, Shannon KM, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999;93:459-66.

Macmillan ML, Davies SM, et al. Haematopoietic cell transplantation in children with juvenile myelomonocytic leukemia. Br J Haematol 1998;103:552-8.

Passamore SJ, Hann CA, et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995;85:1742-50.

Woods WG, Barnard DR, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome. J Clin Oncol 2002;20:434-40.

Was this article helpful?

0 0

Post a comment